CTMX
CytomX Therapeutics Inc

4,444
Mkt Cap
$913.26M
Volume
13.4M
52W High
$5.70
52W Low
$0.40
PE Ratio
12.89
CTMX Fundamentals
Price
$5.39
Prev Close
$4.25
Open
$4.25
50D MA
$4.11
Beta
1.39
Avg. Volume
2.74M
EPS (Annual)
$0.3761
P/B
8.29
Rev/Employee
$1.14M
Loading...
Loading...
News
all
press releases
CytomX Stock Rises 31% in a Month: Here's What You Should Know
CTMX's share jumps 31% in a month after it outlined pipeline progress and 2026 goals led by Varseta-M in advanced colorectal cancer.
Zacks·6h ago
News Placeholder
More News
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Reaches New 12-Month High - Here's What Happened
CytomX Therapeutics (NASDAQ:CTMX) Hits New 12-Month High - Should You Buy...
MarketBeat·3d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year High - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Hits New 52-Week High - Should You Buy...
MarketBeat·17d ago
News Placeholder
237,081 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Precision Wealth Strategies LLC
Precision Wealth Strategies LLC bought a new position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the third quarter, according to the company in its most recent 13F...
MarketBeat·24d ago
News Placeholder
Inspire Investing LLC Acquires Shares of 522,482 CytomX Therapeutics, Inc. $CTMX
Inspire Investing LLC bought a new position in CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·24d ago
News Placeholder
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven analysts that are presently covering the stock...
MarketBeat·25d ago
News Placeholder
CytomX Therapeutics (NASDAQ:CTMX) Trading Up 5.4% - Here's Why
CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 5.4% - What's Next...
MarketBeat·26d ago
News Placeholder
5,769,230 Shares in CytomX Therapeutics, Inc. $CTMX Acquired by Vivo Capital LLC
Vivo Capital LLC bought a new position in CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission...
MarketBeat·1mo ago
News Placeholder
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven brokerages that are covering the firm, MarketBeat reports. One...
MarketBeat·2mo ago
News Placeholder
Franklin Resources Inc. Invests $13.10 Million in CytomX Therapeutics, Inc. $CTMX
Franklin Resources Inc. bought a new stake in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·2mo ago
<
1
2
...
>

Latest CTMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.